This section of the website is for UK Healthcare Professionals only. 
If you are not a Healthcare Professional, please click here.

Cholestasis Academy Live UK Webinar: Q&A

Primary Biliary Cholangitis (PBC) Video
23:15

Join Dr. Kuldeep Cheent, Consultant Gastroenterologist and Hepatologist at Frimley Park Hospital, Frimley Health NHS Foundation Trust, and Dr. Yiannis Kallis, Consultant Hepatologist, Barts Health NHS Trust; Honorary Consultant Transplant Hepatologist, Royal Free London, as they answer key questions from the Cholestasis Academy live webinar held in March. This engaging session covers a range of topics including strategies to improve patient outcomes, the role of PBC audit, the impact of second-line therapies in PBC, and much more.

IQV-UK-000344 | May 2025

Explore more Primary Biliary Cholangitis (PBC) Events & Meetings

Explore more Primary Biliary Cholangitis (PBC) Events & Meetings

Browse

To access relevant information about Primary Biliary Cholangitis, please confirm the following:

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.